Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis.
Jianhua WuSarah L MackieMar Pujades RodriguezPublished in: BMJ open diabetes research & care (2021)
We report dose-dependent risks of type 2 diabetes associated with glucocorticoid use for six common immune-mediated inflammatory diseases. These results underline the need for regular diabetic risk assessment and testing during glucocorticoid therapy in these patients.
Keyphrases
- type diabetes
- risk assessment
- end stage renal disease
- newly diagnosed
- human health
- ejection fraction
- glycemic control
- oxidative stress
- cardiovascular disease
- insulin resistance
- peritoneal dialysis
- prognostic factors
- heavy metals
- skeletal muscle
- climate change
- patient reported
- mesenchymal stem cells
- bone marrow
- replacement therapy
- data analysis